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Abstract 
Medical data privacy is nowadays an alarming issue thanks to the technological revolution witnessed in the medical field and the 
ease of data access and exchange leveraged by newly implemented Hospital Information Systems (HIS). In order to help protect 
patient data while offering them the required medical procedures, many computerized techniques could be made available to be 
implemented in HIS since an early stage of their design. Those techniques should be applied throughout the rolling of clinical 
pathways to preserve medical data privacy and security in order to enhance privacy governance within Hospitals. When considered 
as processes, and because of their complexity and multidisciplinary nature, clinical pathways should be modelled in a simple way 
paying attention to medical tasks and the underlining shared clinical data. It is important to highlight the data with higher protection 
and sensitivity level. These data characteristics will influence many governance and security decisions of each process. This work 
aims to present a methodology to model clinical pathway specifications for data driven clinical processes, distinguishing sensitive 
data from other data and identifying personal data protection principles and the Protected Health Information (PHI). In this context, 
we precise for each clinical task potentially involving data processing and sharing, the level of protection the data requires through 
the use of privacy tags and labels added to data elements predefined using the HL7 standard. This method of tagging would help 
mapping extracted data, cla sified into cat gories, to a set of privacy requirements as needed by the HIPAA legislation. Hence data 
protectio and privacy governa c  are leveraged in a seamless and highly transparent way. The use of HL7 allowed better data 
discov ry and parsing which facilitates the definition of medical data protection measures at a later stage.  
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1. Introduction  
Information technology is nowadays widely implemented in the medical field in order to ensure electronic medical 
data exchanges and communication. Processing and treating medical data increase threats of personal data disclosure 
and illegal use.  This is why; medical data management should comply with personal data protection laws; legislation 
and personal information management standards to ensure their safety while respecting and preserving the patient’s 
privacy. Personal medical data are mostly processed throughout clinical pathways enforced by Hospital Information 
systems. They are shared and communicated between healthcare professionals to ensure care continuity and to enhance 
care quality; sometimes; via secondary use of medical data. Indeed, the necessity of electronic medical data processing 
and management particularly for secondary use purposes such as public health and research increases the risks related 
to its use and disclosure. 
Personal medical data are widely used by all routine and advanced clinical processes. They are useful for medical 
workflows and processes rolling. They are electronically exchanged, manipulated and processed between healthcare 
providers either for direct care or secondary use purposes. For those reasons, high risks of disclosure and illegal use 
of personal data are always present with relation to personal data, medical tasks and processes. Furthermore, security 
measures ought to be defined according to sensitive data types and its underlined privacy risk level in order to enhance 
patient privacy governance within the hospitals’ boundaries and beyond them. However, in order for these privacy 
risks to be evaluated and specified, it is essential to first capture and analyze the existing clinical workflows and 
medical processes responsible for handling and processing the protected data/documents. A first step towards this goal 
should be a clear representation of these automated processes using a standard process modelling language such as 
BPMN (Business Process Model and Notation) [1].  
In this paper, we propose a methodology to enhance privacy governance in HIS throughout clinical business process 
modelling and HL7 standard [9]. Our approach is based on highlighting shared clinical documents throughout 
modelling clinical processes. Then, based on HL7-CDA standard [11], we extracted and identified sensitive data within 
the shared clinical documents. After that, we identified data protection principles and highlighted applicable PHI 
according to the HIPAA legislation [15]. Afterwards, we mapped each sensitive data category to the required 
computerized security method in privacy compliance with HIPAA Privacy Rule which ought to be implemented in 
HIS development to enforce personal data protection. In this work, osteosarcoma was used as a case study to validate 
our approach. 
This paper is divided as follows: in Section 2, we present the osteosarcoma clinical pathway processes subject to 
study as well as the clinical pathway modelling language of our choice. We adopt a data-oriented clinical pathway 
modelling approach. In Section 3, we present our shared clinical data and document architecture retrieved from the 
studied clinical processes and matched with HL7 data and document model. In Section 4, we define personal data 
protection law principles and Privacy requirements for PHI.  Then we identify the set of security labels to be 
implemented for clinical data protection during process execution. Finally, in Section 5, we present the conclusion and 
future work. 
2. Clinical care pathway processes modelling : Osteosarcoma case study  
Oncological pathologies’ care pathways are well-known by their difficult management facts with complex and 
multidisciplinary procedures and processes. They usually require the participation of healthcare providers from 
different medical departments and specialties. These pathways are based on three main phases which are the diagnosis, 
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the treatment and the follow-up procedures. In this work we chose the osteosarcoma as a case study. The osteosarcoma 
is an oncological pathology. It is known as a fetal bone cancer. Besides, it is a primary malignant bone tumor. The 
average of people who are estimated to be diagnosed with osteosarcoma in the United States vary between 800 and 
900 each year. It affects those aged between 10 and 30. Under the microscope, osteosarcomas can be classified 
according to the cells’ behavior as high, intermediate or low grade [2]. 
According to the NCCN (National Comprehensive Cancer Network) and the ESMO (European Society for Medical 
Oncology), the osteosarcoma care pathway includes very complex clinical processes. It begins from the diagnosis, 
going through the treatment and ending with the follow-up. Affected person usually does not feel sick. However, they 
may have a history of pain in the affected area or develop a limp. The felt pain does not go away with rest, it is related 
to muscle soreness or growing pain. As a consequence, the osteosarcoma is discovered further to an injury or a 
pathological fracture (the tumor weakens a bone, so it breaks). The first diagnostic test that patients receive is an x-
ray after visiting the doctor. If it is recognized that a bone cancer is diagnosed then several additional tests are critical 
for the cancer diagnosis and staging. An entire bone MRI should be performed to locate the primary tumor with ruling 
out metastases. A chest x-ray and CT-scan are performed to detect lung metastases. In addition a body bone scan 
(scintigraphy) is performed to rule out distant spread of the tumor. To define the tumor characteristics, a biopsy 
provides a definite diagnosis. Imaging studies and biopsy results allow doctors to stage the cancer and decide about 
the treatment plan. It consists in performing some tests focusing on the heart, kidneys, liver and hearing in order to 
monitor the patient health during treatment. It is principally based on chemotherapy, surgery and radiotherapy 
depending on the patient’s response to the therapy. Once the treatment phase is fulfilled, it is recommended to schedule 
follow up exams and tests. Generally, most appointments include physical exam, original cancer’s location imaging 
and chest imaging. As for the tests, they are periodically done to monitor the heart, the liver, the kidneys, the hearing 
loss as well as checking hormone levels, bone density and cholesterol [3][4]. 
Guidelines on healthcare information processing, communication and sharing between the involved medical 
professionals among medical services within clinical care pathways should be enforced by implemented HISs in 
healthcare facilities. Each clinical pathway includes a set of processes containing on its turn sets of tasks. They are 
carried out throughout the three care pathway typical phases in order to communicate medical documents and clinical 
data as required by the specified care pathway [5]. 
When sensitive clinical data are communicated between healthcare providers, their identification is required for the 
purpose of providing a transparent care pathway standard specification. Besides, their protection is required by 
personal data protection law. Therefore, we modelled the osteosarcoma clinical pathway in the form of clinical 
business process models. In the following subsection, we present the modelled data driven clinical care pathways of 
only the diagnosis phase of the osteosarcoma clinical pathway using the BPMN standard. Other phases of the process 
will be represented in future work. 
2.1. Osteosarcoma diagnosis clinical care pathway 
Fig. 1 presents the diagnosis phase of the osteosarcoma clinical pathway model. It gives attention to the 
communicated clinical documents throughout the care pathways of the diagnosis phase. Besides, it presents the 
process’s steps required by the diagnosis clinical care pathway of the osteosarcoma. According to the physical 
examination and the symptoms findings, some medical tests as medical imaging tests are performed to accomplish 
the check-up phase and identify the pathology. If the imaging findings present any osteosarcoma doubt then a CT 
Scan examination is needed to exclude malignancy. In case cancer malignancy is not excluded then anatomopathology 
test and entire bone MRI are performed in order to confirm the tumor malignancy. Moreover, Bone scintigraphy and 
Thoracic XRay are performed to evaluate metastasis and stage the tumor. The treatment plan and procedure is defined 
according to the all previous findings. As a consequence, the osteosarcoma clinical pathway of the diagnosis phase is 
complex and involves collaboration of healthcare providers and diverse medical services. It is based on the 
communication and the share of several medical documents types (e.g., reports, orders, images, etc.) and subtypes 
(e.g., imaging report, anatomic pathology report, etc.) between healthcare providers within the patient’s Shared 
Medical Record (SMR)[6]. 
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Fig. 1. Osteosarcoma diagnosis clinical pathway business process 
3. Exchanged clinical document architecture 
Patient Electronic Health Record presents a main of patient medical data communication between healthcare 
professionals. It includes all medical data types and medical documents categories. In general, the most used medical 
documents are therapeutic data, nursing notes, problem lists, detailed orders, diagnostic test data, socio-economic data 
and procedure data. Therefore, we could classify medical documents into a set of categories and subcategories. Shared 
and communicated medical document within SHR include all types of clinical documents as medical history record, 
discharge summary, typical paper chart, mental status examination and medical reports like medical tests and operative 
reports. Various clinical data types are used. They could be found in the form of narrative text recorded by clinician, 
numerical measurements (eg. blood pressure, temperature, lab results, etc.), textual data (results reported as a text), 
recorded signals (eg. EKG, EEG, etc.) and pictures (eg. Radiographs, photographs and other images). All the previous 
data are useful for many purposes. They may be used to be the basis of historical record, to support communication 
among providers, to anticipate future health problems, to record standard preventive measures. Besides, they could be 
required for coding and billing, providing legal record or supporting clinical researches.  
Medical data are not only used for patient healthcare but for some secondary uses either. Moreover, medical data 
secondary uses’ purposes are revolving around identifying target patient cohort(s) for clinical trials, observational 
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studies of drug benefits and adverse effects, clinical quality improvement for patients (e.g., for diabetes), monitoring 
errors (e.g., in the emergency room), analyzing rates of use of medication to prevent certain conditions (e.g., blood 
clots) and monitoring the type of lab test requests [7]. Each clinical document is composed of many fragments. It 
provides information about patients, procedures, physicians and assistants, diagnoses, findings and appointments 
within clinical document fragments as shown in [6]. Each data type has a set of specifications to respect. The sensitive 
one should be protected and privacy compliant manner throughout the implementation of privacy requirements since 
an early stage of HIS development. This should be applied to the PHI as required by the HIPAA Privacy Rule [7][8]. 
Based on the HL7-CDA standard, we could map the shared medical documents to a set of characteristics aiming 
to facilitate the representation of the processed medical data throughout the modelled care pathway of the 
osteosarcoma. Each clinical document includes a set of attributes. They provide information about the document name, 
category (e.g., medical reports, medical record, etc.) and its architecture. The included content of the medical 
documents could be classified into a set of metadata, data and values. 
According the CDA standard [9], a clinical document is divided into two main parts. The first part is known as the 
document’s header. It provides information about the document name, type and version. It also affords information 
about participants, organization, etc. As to the second part, it is known as the clinical document’s body. It affords 
information about the body content. So, it details information as the findings, the reason for study, the history, 
procedure context, the study act and the observation. Therefore, we could map the clinical documents content to the 
described structure in [10] 
Each clinical document includes data structured in a hierarchical way that specifies the recommended content in 
the form of sections (eg., participants, authorization, clinical statements, etc.). For example for the participants section 
in the header of the imaging report [11], we found record target representing the patient’s information, author, data 
enterer, information recipient, legal authenticator and participant as sub sections. For each sub section, a set of data 
values are required to be assigned while the document is processed and managed within the patient care pathway 
building the medical processes of the hospital information system. As illustrated in [12], the record target (patient) 
sub section affords information about the patient role which includes address, phone number, patient name, birthdate 
and gender.  
4. Privacy requirements for protecting sensitive data  
Medical data use and management ought to be compliant with international law frameworks of personal data 
protection. Those law frameworks are based on the described data protection principles in [13][14]. Healthcare data 
management presents risks threatening a person’s life and may affect both his privacy as well as his professional life. 
For that, they are governed by many jurisdictions, namely, HIPAA Privacy Rule [15] and the GDPR framework [16]. 
Medical data are used for many purposes. They may be used for the patient healthcare as asking for a second 
opinion, or for research etc. in order to enhance the quality of care. This increased interest in medical information has 
also increased the potential for unauthorized usage and disclosures of personal health information. For each purpose 
of use, there is the involvement of some required and optional data. Therefore, we need the implementation of a 
security adaptable model within HIS to match the required data to its level of sensitivity and security process. Access 
control system implementation is required to protect medical data against any unauthorized process. The adoption of 
data centric care pathways modelling during the development process helps to highlight the medical documents to be 
processed within each process or workflow. It also allows us to detail and classify data within the clinical documents 
into categories indicating its level of sensitivity and demand for protection. The HIPAA Privacy Rule defines a set of 
information called Protected Health Information (PHI) as detailed in [17]. 
This information is considered as individual identifiable information. In addition, HIPAA Privacy Rule has defined 
a set of rules to preserve the patient rights with respect to medical information use and disclosure. According to the 
medical data disclosure purposes, the Privacy Rule defined the access control requirements, the permitted uses and 
disclosures with and without patient consent or authorization and when it is permitted to break the glass [8][18][19]. 
An adaptable security system development to the security requirements is required to help HIS developers to pay 
attention to patient security measures from an early stage of the HIS’s design. This could be used to enforce the 
principle of “minimum necessary” information use [15]. For that, attaching security labels, as the described examples 
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in Table 1, to the medical data is necessary to control human and system behavior while processing sensitive medical 
data. 
Labeling data with security attributes or tags could provide an important mechanism to enhance data protection 
[20]. These labels are widely used for controlling data access according to its sensitivity, which is based on an analysis 
of applicable privacy policies while taking into consideration some related ethical and socioeconomic issues to the 
individual and to the organization controlling the hosted data. Therefore, security labels implementation ensures the 
correlate user and medical document access. This presents a mean defense against data disclosure and unauthorized 
use. When medical data are electronically communicated, it is desirable to enforce security policy throughout the 
processed care pathway. This ensures that the information is not sent to someone that does not have an appropriate 
authorization. This is why we are providing this security model, as illustrated in Table 1, which will be enhanced in a 
future work. Examples of these security labels should include tags related to many properties of the data as described 
in [21]: Usage restriction (i.e. highly restricted, restricted, restricted with exemption and partially restricted use of 
sensitive data that identify the subject). Actual protection status (i.e. in clear, anonymization, encryption, obfuscated, 
watermarked and hidden, has proof of integrity…)[22][23][24][25] and many others. 
Table 1. Examples of security tags for sensitive data. 
 Security tags Examples Description 
Usage 
restrictions 
Loose/non-personal publicly available information: 
business name, phone, email or 
physical address 
Indicating that the information is not classified as 
sensitive. 
 Ordinary logistics, payment, or operations The information is typical and presents typical 
risk of harm if disclosed without authorization. 
 Highly Restricted Information about a victimisation of 
abuse, patient requested information 
sensitivity, etc. 
Indicates that the information is extremely 
sensitive. It presents a very high risk if disclosed 
without authorization 
 Restricted to a group 
of experts 
Sensitive conditions mental health, 
HIV, substance abuse, genetic 
disease, and reproductive health. 
Indicating a high sensitivity of data. It presents a 
high risk to the information subject if disclosed 
without authorization. 
 Restricted with 
Exemption 
A researcher conducts: studying 
treatment outcomes for a certain 
drug.  
Research with human subjects may qualify for an 
exemption. The information is recorded in such a 
manner that subjects cannot be identified, 
directly or through identifiers linked to the 
subjects. 
 Partially Restricted Accessed by a wider range of 
personnel not all of whom are 
actively caring for the patient such 
as radiology staff  
Only some fields of the document should be 
restricted 
Actual 
Protection 
Status 
In clear Care, treatment, payment Requires minimal data protection security in 
order to allow authorised medical users to have 
fast and seamless access to data (or example 
during emergency care). Or other administrative 
data that doesn’t require protection. 
 Anonymized Transfer of information across a 
boundary 
Process of removing personally identifiable 
information from data sets 
 Encrypted  Exchanging medical data using 
email programs 
Transform data into a form in which there is a 
low probability of assigning meaning 
 Obfuscated  preserves privacy of the shared data 
(cluster analysis) 
Embedding identification codes into host media 
 Watermarked Inserting meta-data to render the 
image more usable and information 
protection with application like 
integrity control 
The insertion of a message within the image, also 
called content or watermark message, in a 
host document in some multimedia format 
 Hidden  Users could have only partial access 
to patient data. For example, a 
receptionist could not see results of 
medical tests 
Using SQL queries or database views to filter the 
data before allowing access 
Legal 
compliance and 
safeguards 
 Securing medical records with locks 
and keys or pass codes 
Covered entity must maintain reasonable and 
appropriate administrative, technical, and 
physical safeguards to prevent intentional or 
unintentional use or disclosure of protected 
health information 
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opinion, or for research etc. in order to enhance the quality of care. This increased interest in medical information has 
also increased the potential for unauthorized usage and disclosures of personal health information. For each purpose 
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security adaptable model within HIS to match the required data to its level of sensitivity and security process. Access 
control system implementation is required to protect medical data against any unauthorized process. The adoption of 
data centric care pathways modelling during the development process helps to highlight the medical documents to be 
processed within each process or workflow. It also allows us to detail and classify data within the clinical documents 
into categories indicating its level of sensitivity and demand for protection. The HIPAA Privacy Rule defines a set of 
information called Protected Health Information (PHI) as detailed in [17]. 
This information is considered as individual identifiable information. In addition, HIPAA Privacy Rule has defined 
a set of rules to preserve the patient rights with respect to medical information use and disclosure. According to the 
medical data disclosure purposes, the Privacy Rule defined the access control requirements, the permitted uses and 
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individual and to the organization controlling the hosted data. Therefore, security labels implementation ensures the 
correlate user and medical document access. This presents a mean defense against data disclosure and unauthorized 
use. When medical data are electronically communicated, it is desirable to enforce security policy throughout the 
processed care pathway. This ensures that the information is not sent to someone that does not have an appropriate 
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manner that subjects cannot be identified, 
directly or through identifiers linked to the 
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 Partially Restricted Accessed by a wider range of 
personnel not all of whom are 
actively caring for the patient such 
as radiology staff  
Only some fields of the document should be 
restricted 
Actual 
Protection 
Status 
In clear Care, treatment, payment Requires minimal data protection security in 
order to allow authorised medical users to have 
fast and seamless access to data (or example 
during emergency care). Or other administrative 
data that doesn’t require protection. 
 Anonymized Transfer of information across a 
boundary 
Process of removing personally identifiable 
information from data sets 
 Encrypted  Exchanging medical data using 
email programs 
Transform data into a form in which there is a 
low probability of assigning meaning 
 Obfuscated  preserves privacy of the shared data 
(cluster analysis) 
Embedding identification codes into host media 
 Watermarked Inserting meta-data to render the 
image more usable and information 
protection with application like 
integrity control 
The insertion of a message within the image, also 
called content or watermark message, in a 
host document in some multimedia format 
 Hidden  Users could have only partial access 
to patient data. For example, a 
receptionist could not see results of 
medical tests 
Using SQL queries or database views to filter the 
data before allowing access 
Legal 
compliance and 
safeguards 
 Securing medical records with locks 
and keys or pass codes 
Covered entity must maintain reasonable and 
appropriate administrative, technical, and 
physical safeguards to prevent intentional or 
unintentional use or disclosure of protected 
health information 
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Consent 
necessity 
Individual informed 
consent 
Ask a patient to consent to receiving 
therapy before providing it 
Getting permission before conducting a 
healthcare intervention on a person, or for 
disclosing personal information. 
 Group consent Population genetics research on 
groups 
Used for collecting, processing, use and 
transferral of indigenous samples and data. 
 General consent Receiving diagnostic tests Authorizing the practitioner to render care 
 Specific consent Abortions, sterilization Used in a specific purpose or healthcare 
procedure. 
Intellectual 
property rights 
 Scientific reports discussing a new 
discovery or innovative approach 
involving patient data. 
Any systematic investigation designed to 
develop or contribute to generalizable 
knowledge. 
5. Conclusion and future work  
Data-centric business process modelling applied to care pathway was a necessary step for highlighting shared 
clinical data. Nowadays, the medical field has experienced a revolution with regard to hospital information systems 
and medical procedures processing and management. Therefore, several business process modelling languages such 
as IDEF 0, IDEF 3, UML 2.0 and BPMN, are made available to model and represent clinical pathways [1]. Making 
these process notations more data aware allows clinical care pathways to be more efficient and reliable in preserving 
patient privacy. Within the BMPN care pathway models, we highlighted clinical data used in each process. These data 
elements were associated with their equivalent data elements and documents as defined by HL7-CDA document 
architecture. A detailed description of this phase of the work will be however described in a more extended version of 
the paper. Combining process and data discovery techniques has allowed for a deeper understanding and analysis of 
existing pathologies and the performed activities on the working floor to discover care pathway inefficiencies. 
Modelling care pathways in the form of clinical processes allowed to overcome their complexity and to define their 
requirements regarding patients’ privacy and health care professionals [26][27]. Still, privacy and security challenges 
are increasing while managing medical data with respect to the required technologies implementation [28]. 
In our work we have tackled this issue by defining some general rules of HIPAA privacy requirements with relation 
to patients identifying medical documents, their use and disclosure, since personal data processing must obey to 
privacy protection laws. The adoption of a privacy by design approach offers a better enforcement of privacy since an 
early stage of computer-based healthcare systems design. This puts the emphasis on an orthogonal integration of 
privacy obligations throughout the clinical process using security labels. In this context, we propose in a future work 
to develop an adaptable clinical process model dealing with both the human and the system aspects of privacy 
management when processing protected health data. This will ensure an explicit privacy specification based on clinical 
data highlighting and labelling as part of clinical processes design and implementation. 
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